EAN 2026: How IDH Inhibitors Are Transforming Low-Grade Glioma Treatment

In the Presidential Symposium at EAN 2026, Professor Riccardo Soffietti, Department of Neuro-Oncology, University and City of Health and Science Hospital, Turin, Italy, elaborated on 45 years of advances in low-grade glioma treatment and explained how IDH inhibitors are reshaping first-line therapy after surgery.